Millennium Management’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$68.8K Sell
6,556
-18,918
-74% -$185K ﹤0.01% 5394
2025
Q4
$293K Sell
25,474
-12,402
-33% -$192K ﹤0.01% 5276
2025
Q3
$920K Sell
37,876
-16,067
-30% -$268K ﹤0.01% 4688
2025
Q2
$887K Sell
53,943
-16,621
-24% -$287K ﹤0.01% 4497
2025
Q1
$1.28M Buy
70,564
+56,140
+389% +$1.6M ﹤0.01% 4161
2024
Q4
$535K Buy
+14,424
New +$552K ﹤0.01% 4702
2024
Q2
Sell
-5,486
Closed -$795K 5941
2024
Q1
$795K Sell
5,486
-774
-12% -$65.4K ﹤0.01% 4496
2023
Q4
$577K Buy
+6,260
New +$636K ﹤0.01% 4556
2023
Q3
Sell
-4,122
Closed -$260K 6163
2023
Q2
$260K Buy
+4,122
New +$250K ﹤0.01% 4984
2023
Q1
Sell
-3,904
Closed -$226K 6408
2022
Q4
$226K Sell
3,904
-9,062
-70% -$560K ﹤0.01% 5258
2022
Q3
$1.22M Buy
12,966
+2,641
+26% +$376K ﹤0.01% 4171
2022
Q2
$2.3M Buy
10,325
+9,114
+753% +$3.05M ﹤0.01% 3556
2022
Q1
$666K Buy
1,211
+168
+16% +$102K ﹤0.01% 4890
2021
Q4
$689K Buy
1,043
+303
+41% +$232K ﹤0.01% 4761
2021
Q3
$621K Sell
740
-1,205
-62% -$1.22M ﹤0.01% 5149
2021
Q2
$2.47M Sell
1,945
-1,325
-41% -$1.5M ﹤0.01% 3699
2021
Q1
$3.59M Buy
3,270
+1,209
+59% +$1.6M ﹤0.01% 2952
2020
Q4
$2.94M Sell
2,061
-5,304
-72% -$5.66M ﹤0.01% 2915
2020
Q3
$5.2K Buy
+7,365
New +$5.35M 0.01% 1802
2020
Q2
Sell
-976
Closed -$341K 4196
2020
Q1
$341K Sell
976
-6,154
-86% -$4.36M ﹤0.01% 3102
2019
Q4
$4.48M Sell
7,130
-11,641
-62% -$5.69M 0.01% 2026
2019
Q3
$6.29M Buy
18,771
+12,160
+184% +$3.9M 0.01% 1620
2019
Q2
$1.72M Buy
+6,611
New +$1.32M ﹤0.01% 2499
2018
Q4
Sell
-3,633
Closed -$910K 3779
2018
Q3
$910K Sell
3,633
-5,181
-59% -$1.11M ﹤0.01% 2919
2018
Q2
$1.92M Sell
8,814
-8,876
-50% -$1.64M ﹤0.01% 2436
2018
Q1
$2.59M Buy
+17,690
New +$2.99M ﹤0.01% 2171

Other funds holding CDLX

Millennium Management's CDLX Position: Q1 2026 in Review

Millennium Management reduced its Cardlytics (CDLX) stake by 74% in Q1 2026, selling an estimated $185K and leaving 6,556 shares worth $68.8K. The position accounts for ﹤0.01% of the portfolio, ranked #5394.

Millennium Management first reported a position in CDLX in Q1 2018 and has held it in 26 quarters since. The position peaked at $6.29M in Q3 2019. 58 funds tracked by Wall St. Rank hold CDLX as of Q1 2026.

  • Millennium Management held 6,556 shares of Cardlytics worth $68.8K as of Q1 2026.
  • Millennium Management sold 18,918 Cardlytics shares in Q1 2026, an estimated $185K.
  • Cardlytics made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #5394 holding.
  • Millennium Management first reported a position in Cardlytics in Q1 2018 and has held it in 26 quarters since.
  • Millennium Management's Cardlytics position peaked at $6.29M in Q3 2019.
  • 58 funds tracked by Wall St. Rank held Cardlytics as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.